Molecular Detection Inks Distribution Deal with Eldan for Israel, Palestinian Territories | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Detection and Eldan today announced an exclusive agreement for distribution of MDI's Detect-Ready MRSA panel in Israel and the Palestinian territories.

Financial and other terms of the deal were not disclosed. Eldan, based in Petach Tikva, Israel, is a diagnostic distributor that is part of the Neopharm Group.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.